Characteristics | Number of patients |
---|---|
Menopausal status | |
 Premenopausal | 20 (71%) |
 Postmenopausal | 8 (29%) |
Clinical T stage | |
 T1 | 3 (11%) |
 T2 | 19 (68%) |
 T3 | 3 (11%) |
 T4 | 3 (11%) |
Clinical N stage | |
 N1 | 19 (68%) |
 N2 | 5 (18%) |
 N3 | 4 (14%) |
Histologic tumor characteristic | |
 Ductal | 26 (93%) |
 Ductal vs. lobular | 2 (7%) |
Nuclear grade | |
 Low | 0 |
 Moderate | 13 (46%) |
High | 15 (54%) |
Histologic gradea | |
 Low | 3 (11%) |
 Intermediate | 11 (39%) |
 High | 6 (21%) |
 Missing | 8 (29%) |
HR status | |
 Negative | 11 (39%) |
 Positive | 17 (61%) |
HER2 status | |
 Negative | 20 (71%) |
 Positive | 8 (29%) |